KLOW Stack: Patient Information & Safety Notes
Also known as KLOW peptide blend
Other names: klow-peptide-blend
KLOW is a proprietary injectable blend of BPC-157, TB-500, GHK-Cu, and KPV. The combination has not been studied in human trials and is not FDA-approved.
In plain language
What BPC-157 / TB-500 / GHK-Cu / KPV Blend is used for
- Marketed for recovery and wellness goals, but safety and benefit of the combination are unknown
Taking this medicine
How it is administered
- Subcutaneous injection
What's in it
Ingredients
Read before you decide
Risks and precautions
Risks and warnings
- Injection site irritation
- Mild headache, fatigue, nausea
Who should not take it
- Copper allergy (GHK-Cu component)
Common questions
Patient questions
Is KLOW an FDA-approved product?
No. KLOW is a proprietary compounded blend of research compounds not FDA-approved for any indication.
Related medications
Explore treatment hubs
This information is educational — not medical advice.
This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.
Sources & References
Learn more about where our data comes from and how we write and review medical content.